This HTML5 document contains 34 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
rdfshttp://www.w3.org/2000/01/rdf-schema#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
ncihttp://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
nci:C9982
rdf:type
owl:Class
rdfs:label
Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate/Sargramostim/Vincristine
rdfs:subClassOf
nci:C61063 _:vb662960 _:vb662961 _:vb662956 _:vb662957 _:vb662958 _:vb662959
nci:P106
Therapeutic or Preventive Procedure
nci:P108
Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate/Sargramostim/Vincristine
nci:P207
C0279298
nci:P366
Cyclophosphamide_Doxorubicin_Fluorouracil_Methotrexate_Sargramostim_Vincristine
nci:P90
<n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>CTX/DOX/5-FU/GM-CSF/MTX/VCR</n0:term-name><n0:term-group>AB</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate/Sargramostim/Vincristine</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>
nci:code
C9982
Subject Item
_:vb662956
rdf:type
owl:Restriction
owl:onProperty
nci:R123
owl:someValuesFrom
nci:C456
Subject Item
_:vb662957
rdf:type
owl:Restriction
owl:onProperty
nci:R123
owl:someValuesFrom
nci:C642
Subject Item
_:vb662958
rdf:type
owl:Restriction
owl:onProperty
nci:R123
owl:someValuesFrom
nci:C505
Subject Item
_:vb662959
rdf:type
owl:Restriction
owl:onProperty
nci:R123
owl:someValuesFrom
nci:C405
Subject Item
_:vb662960
rdf:type
owl:Restriction
owl:onProperty
nci:R123
owl:someValuesFrom
nci:C1492
Subject Item
_:vb662961
rdf:type
owl:Restriction
owl:onProperty
nci:R123
owl:someValuesFrom
nci:C933